Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CEL-SCI Corporation (CVM)

3.01   -0.03 (-0.99%) 03-25 14:22
Open: 3.02 Pre. Close: 3.04
High: 3.1427 Low: 2.97
Volume: 261,362 Market Cap: 89M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.173 - 3.191 3.191 - 3.205
Low: 2.969 - 2.99 2.99 - 3.008
Close: 3.008 - 3.04 3.04 - 3.067

Technical analysis

as of: 2019-03-25 1:58:53 PM
Overall:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3.94     One year: 4.60
Support: Support1: 2.75    Support2: 2.37
Resistance: Resistance1: 3.37    Resistance2: 3.94
Pivot: 2.99
Moving Average: MA(5): 3.11     MA(20): 2.92
MA(100): 2.92     MA(250): 2.58
MACD: MACD(12,26): 0.07     Signal(9): 0.06
Stochastic oscillator: %K(14,3): 65.62     %D(3): 76.06
RSI: RSI(14): 53.86
52-week: High: 4.44  Low: 0.82  Change(%): 107.6
Average Vol(K): 3-Month: 28134  10-Days: 26266

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CVM has closed below upper band by 44.8%. Bollinger Bands are 26.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 19 Jan 2019 19:23:00 Z
Trial & Error: The Changing Landscape Of Cancer

Tue, 11 Sep 2018 16:47:57 Z
3 Small Biotech Stocks That Almost Doubled in Past Month

Fri, 07 Sep 2018 14:11:51 Z
Has Cel-Sci (CVM) Outpaced Other Medical Stocks This Year?

Fri, 31 Aug 2018 02:54:25 Z
Thursday Sector Leaders: Medical Instruments & Supplies, Biotechnology Stocks

Wed, 27 Jun 2018 20:08:02 Z
Wednesday Sector Laggards: Biotechnology, Drugs

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 29.57
Shares Float (M) 26.75
% Held by Insiders 21.30
% Held by Institutions 11.80
Shares Short (K) 3150
Shares Short P. Month (K)

Stock Financials

EPS -1.900
EPS Est. Current Year -0.420
EPS Est. Next Year -0.290
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 34.500
PEG Ratio
Profit Margin
Operating Margin -3331.20
Return on Assets (ttm) -101.5
Return on Equity (ttm) 2296.9
Qtrly Rev. Growth 31.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -14.93
Levered Free Cash Flow (M) -12.35

Stock Valuations

P/E -1.58
P/E Growth Ratio -0.01
P/BV 0.09
P/S 4450432512.00
P/CF -5.96

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1996-08-28
Forward Dividend
Last Split Date 2017-06-15
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.